store at low temperature
store at -80°C
Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 189.00 | |
5 mg | In stock | $ 497.00 | |
10 mg | In stock | $ 797.00 |
Description | Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer. |
In vitro | Ensituximab (NEO-102) is a novel chimeric monoclonal antibody that targets a glycosylated variant of MUC5AC, exhibiting specificity for colorectal and pancreatic cancers. Preclinical data indicate that ensituximab selectively targets MUC5AC-positive tumors while sparing MUC5AC antigen in non-malignant tissues.[2]. |
Synonyms | NPC-1C, NEO-102, NEO-101 |
Molecular Weight | N/A |
CAS No. | 1092658-06-4 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ensituximab 1092658-06-4 NPC-1C NEO-102 NEO-101 inhibitor inhibit